Active Ingredient Ustekinumab
Active Ingredient Details
What is Ustekinumab?
A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
What is the usage for Ustekinumab?
Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.
How many products in the NDC database contain Ustekinumab?
The NDC database has 4 products with the active ingredient Ustekinumab. The following table lists all the products that have this active ingredient.
NDC Products with Ustekinumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 57894-054 | Proprietary Name: Stelara | Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
| 57894-060 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
| 57894-061 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
| 65267-896 | Proprietary Name: | Ustekinumab | Injection | Janssen Pharmaceutical Sciences Unlimited Company | ACTIVE |